ǰÑÔ
ÈËÀàȱѪÐÔÐÄÔಡ°üÀ¨ÐĽÊÍ´ºÍÐ£ËÀ£¬²¢Çһᱬ·¢Ðļ¡ÏËά»¯ºÍÐÄË¥¡£µ¼ÖÂÐļ¡È±ÑªµÄ×î³£¼ûÔµ¹ÊÔÓÉÊÇÖ¸¹Ú×´¶¯ÂöÖàÑùÓ²»¯»ù´¡ÉÏ£¬¹Ú×´¶¯Âö¾·ÂλòÛÕ±Õµ¼ÖÂÐļ¡È±ÑªÈ±Ñõ»ò»µËÀ£¬¼´¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ(coronary atherosclerotic heart disease)£¬¼ò³Æ¹ÚÐIJ¡¡£Ëü²»µ«ÔÚÅ¹ú¼Ò³£¼û£¬ÔÚÎÒ¹úÒ²³ÊÖðÄêÔöÌíÇ÷ÊÆ£¬½üÄêÀ´³ÉΪÎÒ¹úéæÃüÂÊǰÁ½Î»µÄ¼²²¡Ö®Ò»¡£Õë¶Ô¹ÚÐIJ¡µÄÒ©ÎïÆÀ¼Û£¬Ò»Ö±Ã»ÓкÜÀû±ãÊÊÓõ͝ÎïÄ£×Ó£¬Ö÷ÒªÓÉÓÚ±£´æÒ»Ð©Ç·ºÃ½â¾öµÄÄÑÌâ¡£Ê×ÏÈ£¬ÊÖÊõÓÕ·¢ÀàµÄÄ£×Ó£¬ÊÖÒÕÄѶȴó£¬ÌØÊâÔÚС¶¯ÎïÉϲÙ×÷µÄÒ»ÖÂÐÔÇ·ºÃ¿ØÖÆ£¬¶ø´ó¶¯Îï¹ØÓÚÒ©ÎïÆÀ¼Û²»ÊǺܱ㵱£¬Ð¡¶¯Îïͬʱ»¹±£´æÐĵç¼à¿ØµÈרҵÒÇÆ÷µÄÏÞÖÆ¡£ÁíÍ⣬ÈËÀàÐÄѪ¹ÜÏµÍ³ÌØµãÒÔ¼°ÔÚijЩÇéÐÎÒòËØ£¨ÈçÓ¦¼¤£©Ï·¢²¡µÄÌØµã£¬ÔÚ³£ÓõÄС¶¯ÎïÄ£×ÓÉ϶¼ºÜÄÑÄ£Ä⣬ÏÖÓÐÄ£×ÓºÍÈËÀ༲²¡µÄÏÖÕæÏàÐβî±ðºÜ´ó¡£¾¡¿ÉÄÜÄ£ÄâÈËÀ༲²¡µÄ²¡ÒòºÍ²¡Àí»úÖÆ£¬ÎªÑ°ÕÒȱѪÐÔÐÄÔಡµÄ·ÀÖβ½·¥ÌṩºÜºÃµÄÑо¿Æ½Ì¨£¬ÊÇÕâÀàÄ£×ÓÑо¿µÄÉú³¤Æ«Ïò¡£
ÓÉÓÚСÊó¶¯ÂöÖàÑùÓ²»¯²¡±äµÄ²¿Î»¾ÖÏÞÓÚ×Ô¶¯Âö£¬Í¨Ë×ÔìÄ£·½·¨²»¿ÉÄ£ÄâÈËÀà¹ÚÐIJ¡×ÔÈ»·¢²¡Àú³Ì£¬Òò´ËСÊóµÄ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ÐÔÐÄÔಡģ×Ó£¬ÖƱ¸ºÜÊÇÄÑÌâ¡£ÔÚ»ùÒòÐÞÊÎСÊóÄ£×Ó´ó×Ú·ºÆðÒÔºó£¬Ò»Ð©ÌØÊâµÄÄ£×ÓÖð½¥±»·¢Ã÷ÓÐ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐ£ËÀ»òÕß¾ßÓÐÇéÐÎÖ²¡ÒòËØÒ׸ÐÐÔ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
ͨ¹ý¶à»ùÒòÐÞÊΣ¬ÔÚÓ°ÏìÖ¬´úл¡¢Ñª¹Ü±Úϸ°ûµÈ¶àÖÖ»ùÒò¹¦Ð§Òì³£ÇéÐÎÏ£¬Ôì³ÉºÜÊÇÑÏÖØµÄ¶¯ÂöÖàÑùÓ²»¯£¬Ê¹²¡±äÖð½¥ÀÛ¼°ÐÄÄÔѪ¹Ü¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
¶à»ùÒòÐÞÊλù´¡ÉÏ£¬ÔöÌíÒûʳ»òÓ¦¼¤µÈÇéÐÎÒòËØ£¬Ä£ÄâÈËÀà¹Ú×´¶¯ÂöÓ²»¯×ÔÈ»±¬·¢Àú³Ì¡£
¡¾ÔìÄ£ÌØµã¡¿£º
SR-BI/ApoEË«»ùÒòÇóýСÊó·ºÆðÏÔÖøÉý¸ßµÄ¸ßÃܶÈÖ¬ÂѰף¬¶øÓÎÀ뵨¹Ì´¼ÏÔÖøÉý¸ß£¬Ñª½¬ÖУ¬ÆäÓ뵨¹Ì´¼º¨µÄ±ÈÀý(FC/CE)ÏÔÖøÉý¸ß³ÉΪ¸ÃÄ£×ÓµÄÌØµã¡£¸ÃÄ£×Ó8ÖÜÄÚ»ù±¾¶¼·ºÆð¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐĹ££¬éæÃüÂʼ«¸ß¡£n/i/eNOSÈý»ùÒòÇóýСÊó³öÉú8¸öÔÂ×óÓÒ°ëÊýÒÔÉÏËÀÓÚÐĹ£¡£¸ÃÄ£×ÓѪ½¬µÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼º¬Á¿Éý¸ß£¬¹Ú×´¶¯Âö±¬·¢ÏÔ×ŵÄÄÚĤÔöÉúºÍÖÐĤ±äºñ£¬¹ÜÖܰé·Ê´óϸ°û½þÈó£¬ÍƲâ¹Ú×´¶¯ÂöÓ²»¯ºÏ²¢¾·Âε¼Ö¸ÃÄ£×ÓÐĹ£¡£
ÏÂÃæËùÁеÄÄ£×Ó£¬¾ùÒѾ±¨µÀÔÚÇéÐÎÒòËØ×÷ÓÃÏ£¬ÌåÏÖ¹Ú×´¶¯ÂöÓ²»¯ºÍÐĹ££¬°üÀ¨eNOS/ApoEË«ÇóýСÊó¡¢SR-BI-/-/HypoEСÊó¡¢SR-BI/LDLrË«ÇóýСÊó¡¢uPA-Tg/ApoE-/-СÊó¡¢Akt1/ApoEË«ÇóýСÊó¡¢PDZKI/ApoEË«ÇóýСÊó¡¢ApoE/LDL-RË«ÇóýСÊó¡£ÕâЩģ×ÓÓи÷×ÔÏà¹ØµÄÖ¬´úÐ»ÌØµã£¬Í¬Ê±¾ßÓÐÔÚ¸ßÖ¬ÒûʳµÈÒòËØµÄ¸ººÉÏ£¬Ò»¶¨Ë®Æ½ÉÏ£¬ÈËΪ¿ØÖÆÐĹ£µÄ±¬·¢Ê±¼äºÍ¹Ú×´¶¯Âö²¡±äˮƽ¡£
¡¾Ä£×ÓȪԴ¡¿£º
´ó´ó¶¼Ð¡ÊóÄ£×Ó¿ÉÒÔ´ÓÃÀ¹úJacksonʵÑéÊÒ(bttp://www.jax.org/index.html)¡¢MMRRC (Mutant Mouse Regional Resource Centers£¬http:// www.mmrrc.org)ºÍ¹ú¼ÒÒÅ´«¹¤³ÌСÊó×ÊÔ´¿â(http://www.nrcmm.cn/mice/index.asp)»ñµÃ¡£´Ó±±¾©´óѧҽѧ²¿ÐÄѪ¹ÜÑо¿Ëù¿ÉÒÔ»ñµÃ²¿·Ö¶¯ÎïÄ£×Ó¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
»ùÒòÐÞÊÎÊÖÒÕʹ¹ÚÐIJ¡Ð¡ÊóÄ£×ÓÖÆ±¸³ÉΪ¿ÉÄÜ£¬×÷ΪÈËÀà¹ÚÐIJ¡Ô¤·ÀºÍÖÎÁÆÑо¿µÄ¹¤¾ß£¬ÓÉÓÚСÊóÔÚÆÊ½â½á¹¹¡¢´úлµÈÐÄÀí¹¦Ð§µÄµ÷ÀíÉÏÓëÈËÀà±£´æ½Ï´ó²î±ð£¬Æä¹ÚÐIJ¡²¡±äÌØµãÓ벿λºÍÈËÀ಻ÍêȫһÖ£¬Ê¹µÃСÊóÄ£×ÓµÄÓ¦ÓÃÊܵ½Öî¶àÏÞÖÆ£¬ÆÀ¼ÛÐÂÒ©Ò²±£´æ½Ï´óΣº¦¡£
ÆäËû¶¯ÎïÈç´óÊó(JCR:LA-cp rat¡¢CETP Tg rat)¡¢µØÊó¡¢¼ÒÍᢸ롢ÖíÒÔ¼°·ÇÈËÁ鳤ÀàµÄºãºÓºï£¬¶¼ÓÐ×Ô¾õ¹Ú×´¶¯ÂöÓ²»¯µÄ±¨µÀ£¬ÌØÊâÊÇ×î½ü±¨µÀµÄPCSK9ת»ùÒòСÐÍÖí£¬ÓÉÓÚÖíÔÚÐÄѪ¹Ü¼²²¡Ä£×ÓÖеÄÌØÊâÓÅÊÆ£¬ÓпÉÄܳÉΪÀíÏëµÄ¹ÚÐIJ¡¶¯ÎïÄ£×Ó¡£
²Î¿¼ÎÄÏ×£º
1.ÕÅ¿¡Ò壬ÍõÕýÖÒ£¬´÷ºìÑÞ£¬µÈ£®´óÊóÐ£ËÀÄ£×ÓÖÆ×÷ÒªÁì̽ÌÖ£®Çൺ´óѧҽѧԺѧ±¨£¬2013,49(2):121-123
2.¹ùˆÅ£¬ºÂ࣬Àî·å½Ü£¬µÈ£®BeagleÈ®ÓëÔÓÖÖÈ®¼±ÐÔÐ£ËÀÄ£×ӵĽÏÁ¿£®ÖйúÖÐÒ©ÔÓÖ¾£¬2013,28 (12):2001-2004
3.Cozen AE, Moriwaki H, Kremen M, el al. Macrophage targeted overexpression of urokinase causes acceleratedatherosclerosis,coronary artery occlusions, and premature death. Circulation, 2004,09 (17):2129-2135
4.Cullen P,Baella R,Bellosla S,el al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vase Biol, 2003, 23 (4):535-542
5.Fernandez-Hernando C,Ackah E, Yu J,el al. Loss of Aktl leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab,2007, 6 (6):446-457
6.Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis,aortic aneurysm formation, and ischernic heart disease in apolipoprotein E/endolhelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104 (4):448-454
7.Nakata S, Tsutsui M, Shimokawa H,et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 2008, 117 (17):2211- 2223
8.Shiomi M,Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of devel opment: a tribute to the late Dr. Yoshio Watanabe., Atherosclerosis, 2009, 207 (1):1-7
9.Trigalli B, Rayburn H, Viiials M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A, 1999,96 (16):9322-9327
10.Zhang S,Picard MH, Vasile E,et al. Diel-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction,and premature death in scavenger receptor class B lype 1-deficient,hypomorphic apolipoprotein ER61 mice. Circulation, 2005, 111(25): 3457-3464